<p>Strain-specific protection threshold of inactivated Nakayama Japanese encephalitis virus vaccine.</p
<p>Amino acid variations between the Nakayama vaccine strain and the GIII brain-isolated CJN strain ...
The Japanese encephalitis virus (JEV) serocomplex, which also includes Murray Valley encephalitis vi...
[[abstract]]The antigenic properties of nine wild-type Japanese encephalitis viruses isolated in Tai...
<p>Strain-specific protection threshold of Japanese encephalitis virus vaccine.</p
Genotype I (GI) Japanese encephalitis virus (JEV) that replaced GIII virus has become the dominant c...
Background: Genotype I (GI) Japanese encephalitis virus (JEV) that replaced GIII virus has become th...
Among vaccinees given two doses of JE Nakayama strain liquid vaccine, 41.8 % had significant neutral...
<p>Japanese encephalitis risk reduction at different vaccine efficacies (VE) for the vaccine only mo...
Current Japanese encephalitis vaccines are derived from strains of genotype III, yet heterologous ge...
<p>Protective Effectiveness on Nonrecipients of Immunizing Children and Adolescents With Influenza V...
1<p>Boldface indicates titers significantly different (P<.05) from those for Nakayama virus by pairw...
Japanese encephalitis vaccine : what you need to know [Hindi]hindi_je_ixiaro.pdf2019829
Japanese Encephalitis (JE) is a disease primarily dominant in South East Asia, caused by the Japanes...
The SA 14-14-2 JE vaccine is a live, attenuated vaccine. It was developed and is produced for domest...
The current Japanese encephalitis (JE) vaccine derived from G3 JE virus (JEV) can induce protective ...
<p>Amino acid variations between the Nakayama vaccine strain and the GIII brain-isolated CJN strain ...
The Japanese encephalitis virus (JEV) serocomplex, which also includes Murray Valley encephalitis vi...
[[abstract]]The antigenic properties of nine wild-type Japanese encephalitis viruses isolated in Tai...
<p>Strain-specific protection threshold of Japanese encephalitis virus vaccine.</p
Genotype I (GI) Japanese encephalitis virus (JEV) that replaced GIII virus has become the dominant c...
Background: Genotype I (GI) Japanese encephalitis virus (JEV) that replaced GIII virus has become th...
Among vaccinees given two doses of JE Nakayama strain liquid vaccine, 41.8 % had significant neutral...
<p>Japanese encephalitis risk reduction at different vaccine efficacies (VE) for the vaccine only mo...
Current Japanese encephalitis vaccines are derived from strains of genotype III, yet heterologous ge...
<p>Protective Effectiveness on Nonrecipients of Immunizing Children and Adolescents With Influenza V...
1<p>Boldface indicates titers significantly different (P<.05) from those for Nakayama virus by pairw...
Japanese encephalitis vaccine : what you need to know [Hindi]hindi_je_ixiaro.pdf2019829
Japanese Encephalitis (JE) is a disease primarily dominant in South East Asia, caused by the Japanes...
The SA 14-14-2 JE vaccine is a live, attenuated vaccine. It was developed and is produced for domest...
The current Japanese encephalitis (JE) vaccine derived from G3 JE virus (JEV) can induce protective ...
<p>Amino acid variations between the Nakayama vaccine strain and the GIII brain-isolated CJN strain ...
The Japanese encephalitis virus (JEV) serocomplex, which also includes Murray Valley encephalitis vi...
[[abstract]]The antigenic properties of nine wild-type Japanese encephalitis viruses isolated in Tai...
DOI
Add to ORKG